Materiały źródłowe

• #1 Lewy Body Dementia (LBD): What It Is, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17815-lewy-body-dementia

  Lewy body dementia (LBD) is a common type of dementia that happens when clumps of proteins called Lewy bodies build up in your brain. They damage parts of your brain that affect cognition, behavior, movement and sleep. LBD is a progressive condition, meaning it gets worse over time. Theres no cure, but medications and therapies can help manage symptoms. […] Diagnosing Lewy body dementia (LBD) can be challenging. Early LBD symptoms are often confused with symptoms found in other brain or psychiatric conditions. […] There are no medical tests that can diagnose Lewy body dementia with 100% accuracy. A diagnosis may require a group of specialists, including neurologists, geriatric psychiatrists, neuropsychologists, and geriatricians. […] Along with a history of progressive cognitive decline that interferes with daily activities, a diagnosis of LBD is considered probable if two of the following four core features are present and is considered possible if only one is present: fluctuations in cognition and behavior, recurrent visual hallucinations, rapid eye movement (REM) sleep behavior disorder, and parkinsonism.

• #2 Dementia with Lewy bodies (DLB) | Symptoms & Causes | alz.org

  https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/dementia-with-lewy-bodies

  Dementia with Lewy bodies (DLB) is a type of progressive dementia that leads to a decline in thinking, reasoning and independent function. […] As with other types of dementia, there is no single test that can conclusively diagnose dementia with Lewy bodies. Today, DLB is a „clinical” diagnosis, which means it represents a doctor’s best professional judgment about the reason for a person’s symptoms. […] The only way to conclusively diagnose DLB is through a postmortem autopsy. […] Most experts believe that dementia with Lewy bodies and Parkinson’s disease dementia are two different expressions of the same underlying problems with brain processing of the protein alpha-synuclein. […] They recommend continuing to diagnose DLB and Parkinson’s disease dementia as separate disorders. […] The diagnosis is DLB when a person experiences dementia either before, at the same time as, or within one year of the onset of symptoms of Parkinsons disease. […] Since Lewy bodies usually coexist with Alzheimer’s brain changes, it may sometimes be hard to distinguish DLB from Alzheimer’s disease, especially in the early stages.

• #3 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies/32136/

  Knowledge of the latest research findings will equip neurologists with the clinical insight necessary to navigate the complexities of dementia with Lewy bodies, enhancing patient care and outcomes. Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia, affecting about 1.5 million people in the United States, but it is underrecognized and often mismanaged in clinical practice. A delayed or nonspecific diagnosis adds to the burden that individuals with DLB and their caregivers experience, and increases the risk of lack of treatment or inappropriate medication use. This review aims to provide practicing neurologists with a comprehensive overview of DLB, encompassing its clinical presentation, diagnostic criteria, and management strategies. […] Diagnostic criteria for a clinical diagnosis of DLB were revised by the DLB Consortium and published in their fourth consensus report in 2017. These criteria have high specificity, but until recently there was no consensus on standard methods to assess signs and symptoms to improve the sensitivity of a DLB diagnosis. However, there are now several tools or sets of instruments that can be used to assess DLB signs and symptoms in a standardized fashion.

• #4 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging

  https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis

  Diagnosing LBD can be challenging. […] It may take more than one visit with a clinician to diagnose a person with LBD. […] Receiving an accurate diagnosis may be a long process, but the good news is that doctors are increasingly able to diagnose both forms of LBD earlier and more accurately as researchers identify which symptoms help distinguish them from similar disorders. […] Getting an accurate diagnosis of LBD early on is important so that a person can get the right medical care and avoid potentially harmful treatment. […] Doctors perform physical and neurological examinations and various tests to distinguish LBD from other illnesses. […] No single brain scan or medical test can definitively diagnose LBD. Currently, LBD can be diagnosed with certainty only by a brain autopsy after death. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.

• #5 The Difficulty With Diagnosing Lewy Body Dementia in Patients – Altoida

  https://altoida.com/blog/difficulty-with-diagnosing-lewy-body-dementia/

  Diagnosing Lewy body dementia is notoriously challenging. For people living with Lewy body dementia, this often means a lengthy journey to diagnosis, seeing several doctors and undergoing many tests before reaching a correct diagnosis. […] Despite being the second most common cause of dementia, Lewy body dementia is the most misdiagnosed dementia, according to the Lewy Body Dementia Association (LBDA). In a 2010 survey, the LBDA found that nearly 80% of people with Lewy body dementia received a diagnosis for a different cognitive, movement, or psychiatric disorder before ultimately learning they had Lewy body dementia. […] Similar to many other causes of dementia, there is no single test that can definitively diagnose Lewy body dementia. Instead, it is diagnosed clinically, meaning the diagnosis is dependent on medical history, answers to certain questions, a physical examination, and the presence of specific physical symptoms.

• #6 The Difficulty With Diagnosing Lewy Body Dementia in Patients – Altoida

  https://altoida.com/blog/difficulty-with-diagnosing-lewy-body-dementia/

  Diagnosing Lewy body dementia is notoriously challenging. For people living with Lewy body dementia, this often means a lengthy journey to diagnosis, seeing several doctors and undergoing many tests before reaching a correct diagnosis. […] Despite being the second most common cause of dementia, Lewy body dementia is the most misdiagnosed dementia, according to the Lewy Body Dementia Association (LBDA). In a 2010 survey, the LBDA found that nearly 80% of people with Lewy body dementia received a diagnosis for a different cognitive, movement, or psychiatric disorder before ultimately learning they had Lewy body dementia. […] Similar to many other causes of dementia, there is no single test that can definitively diagnose Lewy body dementia. Instead, it is diagnosed clinically, meaning the diagnosis is dependent on medical history, answers to certain questions, a physical examination, and the presence of specific physical symptoms.

• #7 Providing the Right Diagnosis for Lewy Body Dementia Patients – InventUMPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–button

  https://news.med.miami.edu/providing-the-right-diagnosis-for-lewy-body-dementia-patients/

  “In a different study, we found that patients averaged 18 months, and had to see more than three physicians on multiple visits, before they finally got a diagnosis,” said Dr. Galvin. “An incorrect first diagnosis was given around 75% of the time.” […] Previous diagnostic approaches lacked the granularity to make differential diagnoses between these conditions. Dr. Galvin and colleagues believe this new module will provide the necessary information to delineate these very different conditions and drive more rapid and precise diagnoses. […] For clinicians, the diagnostic tool will help them provide better care. […] “It allows physicians to perform correct differential diagnoses to offer advanced care planning and treatments,” said Dr. Galvin. “It will also help them avoid medicines that are potentially deleterious to patients and decide who’s going to be eligible for new medicines as they are developed.”

• #8 Getting a diagnosis of dementia with Lewy bodies (DLB) | Alzheimer’s Society

  https://www.alzheimers.org.uk/about-dementia/types-dementia/dementia-with-lewy-bodies-diagnosis

  Dementia with Lewy bodies (DLB) may account for up to 20% of all recorded dementia, but it is often misdiagnosed. […] It is important to know the specific type of dementia a person has, especially if its possible they may have dementia with Lewy bodies (DLB). […] This is because the drugs used to treat hallucinations and delusions in other types of dementia can cause a bad reaction in a person with DLB. […] Dementia with Lewy bodies can sometimes be hard to recognise. People with DLB are often mistakenly diagnosed as having another type of dementia, such as Alzheimers disease. […] DLB may also be mistaken for delirium particularly if the person is first seen by medical staff during an emergency admission to hospital. […] There is more than one way to assess whether a person may have dementia, and the process can vary.

• #9 Dementia with Lewy Bodies (DLB) – PsychDB

  https://www.psychdb.com/geri/dementia/lewy-body

  Possible DLB can be diagnosed if: a. Only 1 core clinical feature of DLB is present, with no indicative biomarker evidence, or b. 1 or more indicative biomarkers is present but there are no core clinical features. […] The presence REM sleep behaviour disorder is a highly specific predictor of Lewy-related pathology, and is suggestive of a 90% likelihood of a synucleinopathy. […] Cognitive tests like the Mini-Mental Status Exam (MMSE) and Montreal Cognitive Assessment (MoCA) are useful to characterize global impairment. […] Typical and High Potency Antipsychotics are CONTRAINDICATED in Lewy Body Dementia! A severe sensitivity reaction occurs in an estimated 25-50% of Dementia with Lewy Bodies (DLB) patients administered typical antipsychotic drugs (especially haloperidol). […] Acetylcholinesterase inhibitors should be the first medications used to treat hallucinations and agitation in patients with DLB. Both rivastigmine and donepezil are effective in DLB for improving cognition, global function, and activities of living.

• #10 Diagnosis and management of dementia with Lewy bodies

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5496518/

  The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. […] The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these. […] Substantial new information has been incorporated about previously reported aspects of DLB, with increased diagnostic weighting given to REM sleep behavior disorder and 123iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. […] The diagnostic role of other neuroimaging, electrophysiologic, and laboratory investigations is also described. […] Minor modifications to pathologic methods and criteria are recommended to take account of Alzheimer disease neuropathologic change, to add previously omitted Lewy-related pathology categories, and to include assessments for substantia nigra neuronal loss.

• #11 Dementia with Lewy bodies – Wikipedia

  https://en.wikipedia.org/wiki/Dementia_with_Lewy_bodies

  Dementia with Lewy bodies (DLB) is a type of dementia characterized by changes in sleep, behavior, cognition, movement, and regulation of automatic bodily functions. […] The disease worsens over time and is usually diagnosed when cognitive impairment interferes with normal daily functioning. […] A presumptive diagnosis can be made if several disease features or biomarkers are present; the diagnostic workup may include blood tests, neuropsychological tests, imaging, and sleep studies. A definitive diagnosis usually requires an autopsy. […] Diagnosing DLB can be challenging because of the wide range of symptoms with differing levels of severity in each individual. […] The essential feature is dementia; for a DLB diagnosis, it must be significant enough to interfere with social or occupational functioning.

• #12 Dementia with Lewy bodies – Wikipedia

  https://en.wikipedia.org/wiki/Dementia_with_Lewy_bodies

  The four core clinical features are fluctuating cognition, visual hallucinations, REM sleep behavior disorder, and signs of parkinsonism. […] Probable DLB can be diagnosed when dementia and at least two core features are present, or when one core feature and at least one indicative biomarker are present. Possible DLB can be diagnosed when dementia and only one core feature are present or, if no core features are present, then at least one indicative biomarker is present. […] Direct laboratory-measurable biomarkers for DLB diagnosis are not known, but several indirect methods can lend further evidence for diagnosis.

• #13 Diagnosis of Dementia with Lewy Bodies (DLB)

  https://reference.medscape.com/calculator/556/diagnosis-of-dementia-with-lewy-bodies-dlb

  Diagnose patients with dementia with Lewy Bodies based on the 2017 criteria […] To be diagnosed with DLB, there is a requirement of the presence of dementia, defined as a progressive cognitive decline which interferes with daily functions. […] For a diagnosis of „probable DLB”, a patient must have either two „core clinical features” or one „core clinical feature” and one „indicative biomarker”. […] If a patient has only one core clinical feature without an indicative biomarker, or an indicative biomarker without a core clinical feature, only a diagnosis of „possible DLB” can be made. […] The Consortium also compiled a list of supportive clinical criteria and supportive biomarkers, but these only provide additional encouragement toward the diagnosis and do not aid in meeting diagnostic criteria.

• #14 Dementia with Lewy bodies – Wikipedia

  https://en.wikipedia.org/wiki/Dementia_with_Lewy_bodies

  The four core clinical features are fluctuating cognition, visual hallucinations, REM sleep behavior disorder, and signs of parkinsonism. […] Probable DLB can be diagnosed when dementia and at least two core features are present, or when one core feature and at least one indicative biomarker are present. Possible DLB can be diagnosed when dementia and only one core feature are present or, if no core features are present, then at least one indicative biomarker is present. […] Direct laboratory-measurable biomarkers for DLB diagnosis are not known, but several indirect methods can lend further evidence for diagnosis.

• #15 LBD Diagnosis & Assessment – Lewy Body Dementia Association

  https://www.lbda.org/lbd-diagnosis-assessment/

  Select a brief standardized instrument sensitive for both amnestic and non-amnestic cognitive decline. The Montreal Cognitive Assessment (MoCA) has become the standard, whereas the Folstein Mini-Mental State Exam (MMSE) is also available, but is often not sensitive enough to detect initial, more-subtle cognitive deficits in LBD. […] Most people with DLB will experience parkinsonism over the course of the disorder, though it may be very subtle or not clinically apparent in the early stage. As such, it is not required for diagnosis. […] Psychiatric symptoms are common and may include anxiety, depression, and psychotic features such as hallucinations and delusions. If visual or other hallucinations occur with mild dementia, it is suggestive of DLB over AD. […] REM sleep behavior disorder (dream enactment) frequently precedes the observed onset of LBD and the sleep partner should be asked about a history of acting out dreams.

• #16 Get Lewy Body Dementia Treatment | Cleveland Clinic

  https://my.clevelandclinic.org/services/lewy-body-dementia-treatment

  Being able to confirm a correct diagnosis means you can have treatments tailored to your needs and symptoms. It can also help you better understand how the disease may develop in the future. […] What to expect at your first appointment […] During your first visit, your care team will likely ask you a lot of questions about your symptoms and how theyre affecting you. What symptoms are you having? When did you first start noticing them? Are they getting worse? […] Well look for a history of decline in thinking that interferes with your daily activities. And well also look for two of the four symptoms that allow us to consider Lewy body dementia as a probable diagnosis changes in behavior and thinking, visual hallucinations, Parkinsonism and rapid eye movement (REM) sleep behavior disorder, which can cause acting out dreams in your sleep.

• #17 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  People who are diagnosed with Lewy body dementia have a gradual decline in the ability to think. They also have at least two of the following: […] Other symptoms support a Lewy body dementia diagnosis. This includes problems with the autonomic nervous system. When this happens, the body isn’t able to regulate blood pressure, heart rate, body temperature and sweating. […] Sensitivity to medicines that treat psychosis also supports a diagnosis. This is particularly true for medicines such as haloperidol (Haldol). Antipsychotic medicines aren’t used for people with Lewy body dementia because they can make symptoms worse. […] No single test can diagnose Lewy body dementia. The diagnosis is based on your symptoms and by ruling out other conditions. […] Your doctor may check for signs of Parkinson’s disease, strokes, tumors or other medical conditions that can affect the brain and physical function.

• #18 Lewy Body Dementia (LBD): What It Is, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17815-lewy-body-dementia

  Lewy body dementia (LBD) is a common type of dementia that happens when clumps of proteins called Lewy bodies build up in your brain. They damage parts of your brain that affect cognition, behavior, movement and sleep. LBD is a progressive condition, meaning it gets worse over time. Theres no cure, but medications and therapies can help manage symptoms. […] Diagnosing Lewy body dementia (LBD) can be challenging. Early LBD symptoms are often confused with symptoms found in other brain or psychiatric conditions. […] There are no medical tests that can diagnose Lewy body dementia with 100% accuracy. A diagnosis may require a group of specialists, including neurologists, geriatric psychiatrists, neuropsychologists, and geriatricians. […] Along with a history of progressive cognitive decline that interferes with daily activities, a diagnosis of LBD is considered probable if two of the following four core features are present and is considered possible if only one is present: fluctuations in cognition and behavior, recurrent visual hallucinations, rapid eye movement (REM) sleep behavior disorder, and parkinsonism.

• #19 Lewy Body Dementia | LBD | MedlinePlus

  https://medlineplus.gov/lewybodydementia.html

  Lewy body dementia (LBD) is one of the most common types of dementia in older adults. […] There isn’t one test that can diagnose LBD. It is important to see an experienced doctor to get a diagnosis. This would usually be a specialist such as a neurologist. […] LBD can be hard to diagnose, because Parkinson’s disease and Alzheimer’s disease cause similar symptoms. […] It’s also important to know which type of LBD a person has, so the doctor can treat that type’s particular symptoms. […] The doctor makes a diagnosis based on when certain symptoms start: […] If cognitive symptoms start within a year of movement problems, the diagnosis is dementia with Lewy bodies […] If cognitive problems start more than a year after the movement problems, the diagnosis is Parkinson’s disease dementia.

• #20 Dementia with Lewy bodies (DLB) | Symptoms & Causes | alz.org

  https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/dementia-with-lewy-bodies

  Dementia with Lewy bodies (DLB) is a type of progressive dementia that leads to a decline in thinking, reasoning and independent function. […] As with other types of dementia, there is no single test that can conclusively diagnose dementia with Lewy bodies. Today, DLB is a „clinical” diagnosis, which means it represents a doctor’s best professional judgment about the reason for a person’s symptoms. […] The only way to conclusively diagnose DLB is through a postmortem autopsy. […] Most experts believe that dementia with Lewy bodies and Parkinson’s disease dementia are two different expressions of the same underlying problems with brain processing of the protein alpha-synuclein. […] They recommend continuing to diagnose DLB and Parkinson’s disease dementia as separate disorders. […] The diagnosis is DLB when a person experiences dementia either before, at the same time as, or within one year of the onset of symptoms of Parkinsons disease. […] Since Lewy bodies usually coexist with Alzheimer’s brain changes, it may sometimes be hard to distinguish DLB from Alzheimer’s disease, especially in the early stages.

• #21 Lewy body dementia | MedLink Neurology

  https://www.medlink.com/handouts/lewy-body-dementia

  Clinicians and researchers use the one-year rule to diagnose which form of LBD a person has. If cognitive symptoms appear within a year of movement problems, the diagnosis is dementia with Lewy bodies. If cognitive problems develop more than a year after the onset of movement problems, the diagnosis is Parkinson’s disease dementia. […] There are no brain scans or medical tests that can definitively diagnose LBD. Currently, LBD can be diagnosed with certainty only by a brain autopsy after death. […] However, researchers are studying ways to diagnose LBD more accurately in the living brain.

• #22 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging

  https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis

  Diagnosing LBD can be challenging. […] It may take more than one visit with a clinician to diagnose a person with LBD. […] Receiving an accurate diagnosis may be a long process, but the good news is that doctors are increasingly able to diagnose both forms of LBD earlier and more accurately as researchers identify which symptoms help distinguish them from similar disorders. […] Getting an accurate diagnosis of LBD early on is important so that a person can get the right medical care and avoid potentially harmful treatment. […] Doctors perform physical and neurological examinations and various tests to distinguish LBD from other illnesses. […] No single brain scan or medical test can definitively diagnose LBD. Currently, LBD can be diagnosed with certainty only by a brain autopsy after death. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.

• #23 Dementia with Lewy bodies – Wikipedia

  https://en.wikipedia.org/wiki/Dementia_with_Lewy_bodies

  Dementia with Lewy bodies (DLB) is a type of dementia characterized by changes in sleep, behavior, cognition, movement, and regulation of automatic bodily functions. […] The disease worsens over time and is usually diagnosed when cognitive impairment interferes with normal daily functioning. […] A presumptive diagnosis can be made if several disease features or biomarkers are present; the diagnostic workup may include blood tests, neuropsychological tests, imaging, and sleep studies. A definitive diagnosis usually requires an autopsy. […] Diagnosing DLB can be challenging because of the wide range of symptoms with differing levels of severity in each individual. […] The essential feature is dementia; for a DLB diagnosis, it must be significant enough to interfere with social or occupational functioning.

• #24 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  People who are diagnosed with Lewy body dementia have a gradual decline in the ability to think. They also have at least two of the following: […] Other symptoms support a Lewy body dementia diagnosis. This includes problems with the autonomic nervous system. When this happens, the body isn’t able to regulate blood pressure, heart rate, body temperature and sweating. […] Sensitivity to medicines that treat psychosis also supports a diagnosis. This is particularly true for medicines such as haloperidol (Haldol). Antipsychotic medicines aren’t used for people with Lewy body dementia because they can make symptoms worse. […] No single test can diagnose Lewy body dementia. The diagnosis is based on your symptoms and by ruling out other conditions. […] Your doctor may check for signs of Parkinson’s disease, strokes, tumors or other medical conditions that can affect the brain and physical function.

• #25 What Is Lewy Body Dementia?

  https://www.alzheimers.gov/alzheimers-dementias/lewy-body-dementia

  Dementia with Lewy bodies is often hard to diagnose early because symptoms may at first look like Alzheimer’s or a mental illness such as schizophrenia. LBD can also occur alongside other forms of dementia. Talking to both the patient and family members or caregivers can help doctors make a diagnosis. It is important to tell the doctor about any symptoms involving thinking, movement, sleep, behavior, or mood. […] To diagnose LBD, doctors may: […] Ask questions about a persons medical history and symptoms. […] Perform physical exams and laboratory tests of blood and other fluids. […] Conduct assessments to evaluate memory and other mental functions. […] Do tests to rule out other conditions that could cause similar symptoms. These could include blood tests and brain imaging tests.

• #26 Lewy Body Dementia (LBD): What It Is, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17815-lewy-body-dementia

  Healthcare providers use the following strategies to help diagnose LBD and to rule out conditions that cause similar symptoms: detailed medical history and physical examination, imaging tests, neurological exam, blood tests, and sleep studies. […] Theres no cure for Lewy body dementia (LBD). Medications and nonmedical therapies, like physical, occupational and speech therapies, manage symptoms as much as possible. […] Medications that can help manage the symptoms of LBD include cholinesterase inhibitors, carbidopa-levodopa, pimavanserin, clonazepam and melatonin, antidepressants, and memantine. […] If you or a loved one are experiencing symptoms of Lewy body dementia, talk to your healthcare provider. […] If youve been diagnosed with Lewy body dementia, youll need to see your healthcare team regularly to monitor your health and symptoms and to make sure your medications are working.

• #27 LBD Diagnosis & Assessment – Lewy Body Dementia Association

  https://www.lbda.org/lbd-diagnosis-assessment/

  Neurological Exam | Motor Assessment | Psychiatric Assessment | Sleep Assessment | Autonomic Assessment | Blood Test and Imaging | DLB Diagnostic Criteria | PDD Diagnostic Criteria […] A thorough neurological examination should be conducted by a clinician experienced in neurodegenerative disorders at the time of the initial assessment. Areas of importance include: Cognitive function, including language and speech Eye movements (can be abnormal in some types of atypical parkinsonism) Gait, balance, fine/coarse motor movements, reflexes Presence of involuntary movements such as tremor Cortical sensory findings, such as assessing sensory abilities to recognize writing on the skin or objects by touch Alteration of smell […] Clinical follow-up should be done in six-month intervals or whenever changes are reported by the patient or family.

• #28 What Is Lewy Body Dementia?

  https://www.alzheimers.gov/alzheimers-dementias/lewy-body-dementia

  Dementia with Lewy bodies is often hard to diagnose early because symptoms may at first look like Alzheimer’s or a mental illness such as schizophrenia. LBD can also occur alongside other forms of dementia. Talking to both the patient and family members or caregivers can help doctors make a diagnosis. It is important to tell the doctor about any symptoms involving thinking, movement, sleep, behavior, or mood. […] To diagnose LBD, doctors may: […] Ask questions about a persons medical history and symptoms. […] Perform physical exams and laboratory tests of blood and other fluids. […] Conduct assessments to evaluate memory and other mental functions. […] Do tests to rule out other conditions that could cause similar symptoms. These could include blood tests and brain imaging tests.

• #29 LBD Diagnosis & Assessment – Lewy Body Dementia Association

  https://www.lbda.org/lbd-diagnosis-assessment/

  Select a brief standardized instrument sensitive for both amnestic and non-amnestic cognitive decline. The Montreal Cognitive Assessment (MoCA) has become the standard, whereas the Folstein Mini-Mental State Exam (MMSE) is also available, but is often not sensitive enough to detect initial, more-subtle cognitive deficits in LBD. […] Most people with DLB will experience parkinsonism over the course of the disorder, though it may be very subtle or not clinically apparent in the early stage. As such, it is not required for diagnosis. […] Psychiatric symptoms are common and may include anxiety, depression, and psychotic features such as hallucinations and delusions. If visual or other hallucinations occur with mild dementia, it is suggestive of DLB over AD. […] REM sleep behavior disorder (dream enactment) frequently precedes the observed onset of LBD and the sleep partner should be asked about a history of acting out dreams.

• #30 Dementia with Lewy Bodies (DLB) – PsychDB

  https://www.psychdb.com/geri/dementia/lewy-body

  Possible DLB can be diagnosed if: a. Only 1 core clinical feature of DLB is present, with no indicative biomarker evidence, or b. 1 or more indicative biomarkers is present but there are no core clinical features. […] The presence REM sleep behaviour disorder is a highly specific predictor of Lewy-related pathology, and is suggestive of a 90% likelihood of a synucleinopathy. […] Cognitive tests like the Mini-Mental Status Exam (MMSE) and Montreal Cognitive Assessment (MoCA) are useful to characterize global impairment. […] Typical and High Potency Antipsychotics are CONTRAINDICATED in Lewy Body Dementia! A severe sensitivity reaction occurs in an estimated 25-50% of Dementia with Lewy Bodies (DLB) patients administered typical antipsychotic drugs (especially haloperidol). […] Acetylcholinesterase inhibitors should be the first medications used to treat hallucinations and agitation in patients with DLB. Both rivastigmine and donepezil are effective in DLB for improving cognition, global function, and activities of living.

• #31 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  A short form of this test, which assesses memory and thinking skills, can be done in less than 10 minutes. […] Longer tests that take several hours help identify Lewy body dementia. […] These can rule out physical problems that can affect brain function, such as vitamin B-12 deficiency or an underactive thyroid gland. […] Your doctor might order an MRI or CT scan to identify a stroke or bleeding and to rule out a tumor. […] If the diagnosis is unclear or the symptoms aren’t typical, you may need other imaging tests. […] These imaging tests may support a diagnosis of Lewy body dementia: […] You may need a sleep evaluation called a polysomnogram to check for REM sleep behavior disorder. […] In some countries, health care professionals also might order a heart test called myocardial scintigraphy. […] Research is ongoing into other indicators of Lewy body dementia. These biomarkers might eventually enable early diagnosis of Lewy body dementia before the full disease develops.

• #32 Patients with dementia with Lewy bodies display a signature alteration of their cognitive connectome | Scientific Reports

  https://www.nature.com/articles/s41598-024-84946-4

  Cognition plays a central role in the diagnosis and characterization of dementia with Lewy bodies (DLB). […] The essential criterion for diagnosing DLB is a progressive cognitive decline. […] In addition, characterization of that cognitive decline plays an important role in the differential diagnosis of DLB. […] The typical cognitive profile of DLB includes deficits in attention, executive functions, and visual abilities, while other domains such as memory can be involved at later stages of the disease. […] This study provides the data to advance the understanding of cognitive impairment and clinical phenotype in DLB, with implications for differential diagnosis. […] The cognitive connectome of DLB shows a loss of segregation, leading to a loss of cognitive specialization. […] We hypothesized prominent alterations in the cognitive connectome of DLB patients in comparison with HC, particularly involving attention, executive, and visual domains.

• #33 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  A short form of this test, which assesses memory and thinking skills, can be done in less than 10 minutes. […] Longer tests that take several hours help identify Lewy body dementia. […] These can rule out physical problems that can affect brain function, such as vitamin B-12 deficiency or an underactive thyroid gland. […] Your doctor might order an MRI or CT scan to identify a stroke or bleeding and to rule out a tumor. […] If the diagnosis is unclear or the symptoms aren’t typical, you may need other imaging tests. […] These imaging tests may support a diagnosis of Lewy body dementia: […] You may need a sleep evaluation called a polysomnogram to check for REM sleep behavior disorder. […] In some countries, health care professionals also might order a heart test called myocardial scintigraphy. […] Research is ongoing into other indicators of Lewy body dementia. These biomarkers might eventually enable early diagnosis of Lewy body dementia before the full disease develops.

• #34 LBD Diagnosis & Assessment – Lewy Body Dementia Association

  https://www.lbda.org/lbd-diagnosis-assessment/

  There is not one standard test used to assess autonomic function in DLB, however, the Non-Motor Symptoms Scale or the Scales for Outcomes in Parkinsons Disease (SCOPA) assessments can be used. […] Reversible causes of dementia (e.g. post-traumatic hydrocephalus, drug and alcohol toxicity, electrolytes, B12 deficiency, HIV, thyroid disorders), though rare in this setting, should be screened for and treated if confirmed. […] Imaging in DLB is usually normal. Dopamine transporter single-photon emission computed tomography (DaT SPECT) of the brain can be done when indicated to differentiate both DLB and PDD from AD. […] In 2017, the international DLB Consortium published updated diagnostic criteria for DLB in the journal Neurology. […] Essential for a diagnosis of DLB is dementia, defined as a progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational functions, or with usual daily activities.

• #35 Getting a diagnosis of dementia with Lewy bodies (DLB) | Alzheimer’s Society

  https://www.alzheimers.org.uk/about-dementia/types-dementia/dementia-with-lewy-bodies-diagnosis

  The doctor may do some blood tests to rule out other causes of the persons symptoms, such as a low level of vitamins in the body or hormone problems. […] The doctor should also check the persons medications. Some drugs used to treat depression, allergies or incontinence can cause confusion. […] The person will be asked to complete tests or activities designed to show if they are having problems with thinking and perception. […] If the person shows signs of DLB, they may have brain or heart scans to help confirm the diagnosis: […] If it still not possible to make a diagnosis, a more specialised scan of the brain can be carried out. This can show the difference between DLB and other types of dementia. […] If there is still doubt, another type of brain scan can confirm a diagnosis of DLB if it shows loss of a particular type of cells (dopamine nerve cells) at the base of the brain.

• #36 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  A short form of this test, which assesses memory and thinking skills, can be done in less than 10 minutes. […] Longer tests that take several hours help identify Lewy body dementia. […] These can rule out physical problems that can affect brain function, such as vitamin B-12 deficiency or an underactive thyroid gland. […] Your doctor might order an MRI or CT scan to identify a stroke or bleeding and to rule out a tumor. […] If the diagnosis is unclear or the symptoms aren’t typical, you may need other imaging tests. […] These imaging tests may support a diagnosis of Lewy body dementia: […] You may need a sleep evaluation called a polysomnogram to check for REM sleep behavior disorder. […] In some countries, health care professionals also might order a heart test called myocardial scintigraphy. […] Research is ongoing into other indicators of Lewy body dementia. These biomarkers might eventually enable early diagnosis of Lewy body dementia before the full disease develops.

• #37 Getting a diagnosis of dementia with Lewy bodies (DLB) | Alzheimer’s Society

  https://www.alzheimers.org.uk/about-dementia/types-dementia/dementia-with-lewy-bodies-diagnosis

  The doctor may do some blood tests to rule out other causes of the persons symptoms, such as a low level of vitamins in the body or hormone problems. […] The doctor should also check the persons medications. Some drugs used to treat depression, allergies or incontinence can cause confusion. […] The person will be asked to complete tests or activities designed to show if they are having problems with thinking and perception. […] If the person shows signs of DLB, they may have brain or heart scans to help confirm the diagnosis: […] If it still not possible to make a diagnosis, a more specialised scan of the brain can be carried out. This can show the difference between DLB and other types of dementia. […] If there is still doubt, another type of brain scan can confirm a diagnosis of DLB if it shows loss of a particular type of cells (dopamine nerve cells) at the base of the brain.

• #38 Lewy Body Dementia (LBD): Diagnosis & Treatment | NewYork-Presbyterian

  https://www.nyp.org/neuro/dementia/lewy-body-dementia-lbd/treatment

  How Is Lewy Body Dementia (LBD) Diagnosed? Diagnosis There is no specific test to diagnose LBD. Diagnosis of LBD involves ruling out other types of dementia and conditions with similar symptoms. To diagnose LBD, a doctor may order the following: […] Physical examination. To rule out other diseases, the doctor will look for signs of Parkinsons disease, strokes, brain tumors, or other medical conditions affecting the brain and physical function. […] Cognitive and psychological tests. Doctors will evaluate the patients thinking ability, memory, language skills, orientation, reasoning, and attention. […] Brain scans. These allow doctors to get a detailed view of the brain. […] CT or MRI scans can detect stroke, bleeding, and brain tumors, which may rule out other types of dementia. […] PET scans (positron emission tomography scans) are not routinely used to confirm Alzheimers disease and LBD diagnoses but may be recommended by a doctor to support a diagnosis. […] DatSCANs (dopamine transporter scans) are often performed to see if there is an underlying dopamine deficiency in cases of LBD with no or mild parkinsonism.

• #39 Dementia with Lewy bodies | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/dementia-with-lewy-bodies?lang=us

  MRI is the modality of choice to structurally image the brain, however, there are no easily identifiable features to specifically support the diagnosis of dementia with Lewy bodies. […] Perhaps, more importantly, the mesial temporal lobe and hippocampi remain relatively normal in size, helping to distinguish Lewy body disease from Alzheimer disease. […] Findings of DLB include loss of dopaminergic neurons in the substantia nigra and related reduced striatal dopaminergic activity, therefore patients with DLB have abnormal striatal uptake on dopamine transporter scans. […] Unlike Parkinson disease, dementia with Lewy bodies respond less readily to L-dopa and also may have severe sensitivity reactions to neuroleptic drugs. […] Lewy body dementia also responds favourably to acetylcholinesterase inhibitors, even more so than Alzheimer disease.

• #40 Lewy Body Dementia (LBD): Diagnosis & Treatment | NewYork-Presbyterian

  https://www.nyp.org/neuro/dementia/lewy-body-dementia-lbd/treatment

  How Is Lewy Body Dementia (LBD) Diagnosed? Diagnosis There is no specific test to diagnose LBD. Diagnosis of LBD involves ruling out other types of dementia and conditions with similar symptoms. To diagnose LBD, a doctor may order the following: […] Physical examination. To rule out other diseases, the doctor will look for signs of Parkinsons disease, strokes, brain tumors, or other medical conditions affecting the brain and physical function. […] Cognitive and psychological tests. Doctors will evaluate the patients thinking ability, memory, language skills, orientation, reasoning, and attention. […] Brain scans. These allow doctors to get a detailed view of the brain. […] CT or MRI scans can detect stroke, bleeding, and brain tumors, which may rule out other types of dementia. […] PET scans (positron emission tomography scans) are not routinely used to confirm Alzheimers disease and LBD diagnoses but may be recommended by a doctor to support a diagnosis. […] DatSCANs (dopamine transporter scans) are often performed to see if there is an underlying dopamine deficiency in cases of LBD with no or mild parkinsonism.

• #41 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/articles/2024-may-june/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies

  The revised diagnostic criteria for a clinical diagnosis of DLB describe 3 indicative biomarkers and several supportive biomarkers. The first indicative biomarker is reduced dopamine transporter uptake in the basal ganglia demonstrated by single-photon emission CT (SPECT) or positron emission tomography (PET), most commonly a DaTscan with the radioligand 123I-ioflupane and SPECT. Sensitivity of 78% and specificity of 90% are reported with DaTscan in differentiating DLB from AD. In the United States, the Centers for Medicare Medicaid Services (CMS) has approved DaTscan in the diagnostic evaluation of people with possible DLB. The second indicative biomarker is polysomnographic confirmation of REM sleep without atonia (RBD). RBD often precedes other symptoms of an -synucleinopathy (including DLB, Parkinson disease, and multiple system atrophy), and the combination of dementia and RBD strongly supports a diagnosis of DLB. The third indicative biomarker is low uptake on 123 (MIBG) myocardial scintigraphy. The MIBG scan has a sensitivity between 69% and 77% and specificity between 87% and 94% for differentiating DLB from AD, depending on the severity of the dementia stage, with better discriminative ability in milder dementia stages.

• #42 Dementia with Lewy bodies | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/dementia-with-lewy-bodies?lang=us

  MRI is the modality of choice to structurally image the brain, however, there are no easily identifiable features to specifically support the diagnosis of dementia with Lewy bodies. […] Perhaps, more importantly, the mesial temporal lobe and hippocampi remain relatively normal in size, helping to distinguish Lewy body disease from Alzheimer disease. […] Findings of DLB include loss of dopaminergic neurons in the substantia nigra and related reduced striatal dopaminergic activity, therefore patients with DLB have abnormal striatal uptake on dopamine transporter scans. […] Unlike Parkinson disease, dementia with Lewy bodies respond less readily to L-dopa and also may have severe sensitivity reactions to neuroleptic drugs. […] Lewy body dementia also responds favourably to acetylcholinesterase inhibitors, even more so than Alzheimer disease.

• #43 Dementia with Lewy bodies diagnosis | Alzheimer’s Research UK

  https://www.alzheimersresearchuk.org/dementia-information/types-of-dementia/dementia-with-lewy-bodies/diagnosis/

  Diagnosing dementia, and where possible which type someone has is important. It ensures someone can receive the right treatments, support and care to help them live well with their condition. […] If the doctor suspects you have dementia, you may be referred to a memory clinic or another specialist clinic where more in depth tests can be done. […] Once we got the referral, my mum was seen by a consultant and she had an MRI scan to rule out a stroke and Parkinson’s. Then we got a letter confirming the diagnosis of dementia with Lewy bodies. It was a massive relief. It helped mum to know that there was something wrong with her; she would tell people ‘I’ve got dementia’, although she didn’t really understand it. […] Brain scans like MRI (magnetic resonance imaging) or CT (computerised tomography), can help to diagnose dementia or rule out other causes of symptoms. […] To help make a specific diagnosis of DLB, a type of scan called a SPECT scan (or ‘DaTscan’) may be used. This type of scan can show changes in the brain that are more common in this type of dementia. However, when symptoms of DLB or PD are quite clear, someone may not need this test.

• #44 Lewy Body Dementia Workup: Approach Considerations, Imaging Studies, Histologic Findings

  https://emedicine.medscape.com/article/1135041-workup

  Patients with DLB usually have less hippocampal atrophy than do patients with Alzheimer disease (but more than control subjects), although whether this difference is clinically useful is under investigation, as is the diagnostic utility of functional imaging. […] SPECT or positron emission tomography (PET) scanning may show decreased occipital lobe blood flow or metabolism in DLB but not in Alzheimer disease. […] A new test, called the Lewy body composite risk score (LBCRS), may help determine whether Lewy body pathology is contributing to dementia. The checklist was derived from clinical features in autopsy-verified cases of healthy controls, Alzheimers disease (AD), DLB, and PD with and without dementia. […] The LBCRS was able to discriminate DLB from other causes of dementia.

• #45 Lewy Body Dementia Symptoms & Treatment | Pacific Brain Health Center

  https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/dementia/lewy-body-dementia/

  Lewy body dementia (LBD) is a neurodegenerative disorder characterized by the presence of abnormal protein deposits called Lewy bodies in the brain. […] The definitive diagnosis of DLB is, unfortunately, based on autopsy. Probable DLB is diagnosed based on the presence of dementia and two of the three core features: visual hallucinations, parkinsonism, and fluctuations of awareness. […] Diagnostic testing can play a role, mainly in the use of DaTscan (which can differentiate between Alzheimers disease and DLB), and PET scan (which can show low metabolism in the occipital lobes, seen in DLB). […] While there are no curative treatments for Lewy Body dementia at this time, at Pacific Neuroscience Institute we are confident that accurate diagnosis is the first step in research opportunities and improved treatment and prevention of progression.

• #46 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/articles/2024-may-june/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies

  The revised diagnostic criteria for a clinical diagnosis of DLB describe 3 indicative biomarkers and several supportive biomarkers. The first indicative biomarker is reduced dopamine transporter uptake in the basal ganglia demonstrated by single-photon emission CT (SPECT) or positron emission tomography (PET), most commonly a DaTscan with the radioligand 123I-ioflupane and SPECT. Sensitivity of 78% and specificity of 90% are reported with DaTscan in differentiating DLB from AD. In the United States, the Centers for Medicare Medicaid Services (CMS) has approved DaTscan in the diagnostic evaluation of people with possible DLB. The second indicative biomarker is polysomnographic confirmation of REM sleep without atonia (RBD). RBD often precedes other symptoms of an -synucleinopathy (including DLB, Parkinson disease, and multiple system atrophy), and the combination of dementia and RBD strongly supports a diagnosis of DLB. The third indicative biomarker is low uptake on 123 (MIBG) myocardial scintigraphy. The MIBG scan has a sensitivity between 69% and 77% and specificity between 87% and 94% for differentiating DLB from AD, depending on the severity of the dementia stage, with better discriminative ability in milder dementia stages.

• #47 Diagnosis and management of dementia with Lewy bodies

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5496518/

  The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. […] The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these. […] Substantial new information has been incorporated about previously reported aspects of DLB, with increased diagnostic weighting given to REM sleep behavior disorder and 123iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. […] The diagnostic role of other neuroimaging, electrophysiologic, and laboratory investigations is also described. […] Minor modifications to pathologic methods and criteria are recommended to take account of Alzheimer disease neuropathologic change, to add previously omitted Lewy-related pathology categories, and to include assessments for substantia nigra neuronal loss.

• #48 Dementia with Lewy Bodies (DLB) – PsychDB

  https://www.psychdb.com/geri/dementia/lewy-body

  Dementia with Lewy Bodies (DLB), is a neurodegenerative disorder associated with abnormal deposits of alpha-synuclein in the brain. DLB is one of the most common causes of dementia. […] Lewy body dementia (LBD) (more correctly, should be referred to as Lewy Body Dementia) is actually an umbrella term that refers either a diagnosis of Dementia with Lewy bodies (DLB) or Parkinson’s disease dementia. […] DLB is estimated to account for around 4.2% of all diagnosed dementias in the community. However, the true prevalence is likely to be much higher because DLB diagnoses are often missed. […] Dementia with Lewy Bodies (DLB) has a very quick progression relative to other dementias such as Alzheimer’s, with an average survival time of 3 to 5 years. […] The presence of REM sleep behaviour disorder is a major risk factor for DLB.

• #49 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  A short form of this test, which assesses memory and thinking skills, can be done in less than 10 minutes. […] Longer tests that take several hours help identify Lewy body dementia. […] These can rule out physical problems that can affect brain function, such as vitamin B-12 deficiency or an underactive thyroid gland. […] Your doctor might order an MRI or CT scan to identify a stroke or bleeding and to rule out a tumor. […] If the diagnosis is unclear or the symptoms aren’t typical, you may need other imaging tests. […] These imaging tests may support a diagnosis of Lewy body dementia: […] You may need a sleep evaluation called a polysomnogram to check for REM sleep behavior disorder. […] In some countries, health care professionals also might order a heart test called myocardial scintigraphy. […] Research is ongoing into other indicators of Lewy body dementia. These biomarkers might eventually enable early diagnosis of Lewy body dementia before the full disease develops.

• #50 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/articles/2024-may-june/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies

  The revised diagnostic criteria for a clinical diagnosis of DLB describe 3 indicative biomarkers and several supportive biomarkers. The first indicative biomarker is reduced dopamine transporter uptake in the basal ganglia demonstrated by single-photon emission CT (SPECT) or positron emission tomography (PET), most commonly a DaTscan with the radioligand 123I-ioflupane and SPECT. Sensitivity of 78% and specificity of 90% are reported with DaTscan in differentiating DLB from AD. In the United States, the Centers for Medicare Medicaid Services (CMS) has approved DaTscan in the diagnostic evaluation of people with possible DLB. The second indicative biomarker is polysomnographic confirmation of REM sleep without atonia (RBD). RBD often precedes other symptoms of an -synucleinopathy (including DLB, Parkinson disease, and multiple system atrophy), and the combination of dementia and RBD strongly supports a diagnosis of DLB. The third indicative biomarker is low uptake on 123 (MIBG) myocardial scintigraphy. The MIBG scan has a sensitivity between 69% and 77% and specificity between 87% and 94% for differentiating DLB from AD, depending on the severity of the dementia stage, with better discriminative ability in milder dementia stages.

• #51 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/articles/2024-may-june/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies

  The revised diagnostic criteria for a clinical diagnosis of DLB describe 3 indicative biomarkers and several supportive biomarkers. The first indicative biomarker is reduced dopamine transporter uptake in the basal ganglia demonstrated by single-photon emission CT (SPECT) or positron emission tomography (PET), most commonly a DaTscan with the radioligand 123I-ioflupane and SPECT. Sensitivity of 78% and specificity of 90% are reported with DaTscan in differentiating DLB from AD. In the United States, the Centers for Medicare Medicaid Services (CMS) has approved DaTscan in the diagnostic evaluation of people with possible DLB. The second indicative biomarker is polysomnographic confirmation of REM sleep without atonia (RBD). RBD often precedes other symptoms of an -synucleinopathy (including DLB, Parkinson disease, and multiple system atrophy), and the combination of dementia and RBD strongly supports a diagnosis of DLB. The third indicative biomarker is low uptake on 123 (MIBG) myocardial scintigraphy. The MIBG scan has a sensitivity between 69% and 77% and specificity between 87% and 94% for differentiating DLB from AD, depending on the severity of the dementia stage, with better discriminative ability in milder dementia stages.

• #52 Dementia with Lewy Bodies (DLB) – PsychDB

  https://www.psychdb.com/geri/dementia/lewy-body

  The diagnostic criteria for Lewy body dementia continues to evolve, and while the DSM-5 provides a guiding diagnostic framework, it was published in 2013, and many new research findings have occurred. […] Essential for a diagnosis of DLB is dementia, defined as a progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational functions, or with usual daily activities. […] Core clinical features (The first 3 typically occur early and may persist throughout the course.) 1. Fluctuating cognition with pronounced variations in attention and alertness. 2. Recurrent visual hallucinations that are typically well formed and detailed. 3. REM sleep behavior disorder, which may precede cognitive decline. […] Probable DLB can be diagnosed if: a. 2 or more core clinical features of DLB are present, with or without the presence of indicative biomarkers, or b. Only 1 core clinical feature is present, but with 1 or more indicative biomarkers.

• #53 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  People who are diagnosed with Lewy body dementia have a gradual decline in the ability to think. They also have at least two of the following: […] Other symptoms support a Lewy body dementia diagnosis. This includes problems with the autonomic nervous system. When this happens, the body isn’t able to regulate blood pressure, heart rate, body temperature and sweating. […] Sensitivity to medicines that treat psychosis also supports a diagnosis. This is particularly true for medicines such as haloperidol (Haldol). Antipsychotic medicines aren’t used for people with Lewy body dementia because they can make symptoms worse. […] No single test can diagnose Lewy body dementia. The diagnosis is based on your symptoms and by ruling out other conditions. […] Your doctor may check for signs of Parkinson’s disease, strokes, tumors or other medical conditions that can affect the brain and physical function.

• #54 Lewy body dementia – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/symptoms-causes/syc-20352025

  Lewy body dementia is the second most common type of dementia after Alzheimer’s disease. […] Lewy body dementia causes a decline in mental abilities that gradually gets worse over time. […] People with Lewy body dementia might experience Parkinson’s disease symptoms. […] Lewy body dementia symptoms can include: […] Seeing things that aren’t there, known as hallucinations, might be one of the first symptoms of Lewy body dementia. […] Signs of Parkinson’s disease, known as parkinsonian signs, may occur. […] Lewy body dementia can affect how well the autonomic nervous system controls blood pressure, heart rate, sweating and digestion. […] People with Lewy body dementia might have thinking problems similar to those of Alzheimer’s disease. […] People with Lewy body dementia can have rapid eye movement (REM) sleep behavior disorder. […] Lewy body dementia is characterized by the buildup of proteins into masses known as Lewy bodies. […] People who have Lewy bodies in their brains also have the plaques and tangles associated with Alzheimer’s disease.

• #55 LBD Diagnosis & Assessment – Lewy Body Dementia Association

  https://www.lbda.org/lbd-diagnosis-assessment/

  There is not one standard test used to assess autonomic function in DLB, however, the Non-Motor Symptoms Scale or the Scales for Outcomes in Parkinsons Disease (SCOPA) assessments can be used. […] Reversible causes of dementia (e.g. post-traumatic hydrocephalus, drug and alcohol toxicity, electrolytes, B12 deficiency, HIV, thyroid disorders), though rare in this setting, should be screened for and treated if confirmed. […] Imaging in DLB is usually normal. Dopamine transporter single-photon emission computed tomography (DaT SPECT) of the brain can be done when indicated to differentiate both DLB and PDD from AD. […] In 2017, the international DLB Consortium published updated diagnostic criteria for DLB in the journal Neurology. […] Essential for a diagnosis of DLB is dementia, defined as a progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational functions, or with usual daily activities.

• #56 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/articles/2024-may-june/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies

  Knowledge of the latest research findings will equip neurologists with the clinical insight necessary to navigate the complexities of dementia with Lewy bodies, enhancing patient care and outcomes. Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia, affecting about 1.5 million people in the United States, but it is underrecognized and often mismanaged in clinical practice. A delayed or nonspecific diagnosis adds to the burden that individuals with DLB and their caregivers experience, and increases the risk of lack of treatment or inappropriate medication use. This review aims to provide practicing neurologists with a comprehensive overview of DLB, encompassing its clinical presentation, diagnostic criteria, and management strategies. […] Diagnostic criteria for a clinical diagnosis of DLB were revised by the DLB Consortium and published in their fourth consensus report in 2017. These criteria have high specificity, but until recently there was no consensus on standard methods to assess signs and symptoms to improve the sensitivity of a DLB diagnosis. However, there are now several tools or sets of instruments that can be used to assess DLB signs and symptoms in a standardized fashion. One of the first was the Lewy Body Composite Score, which includes 5 motor signs of parkinsonism determined by an experienced provider and 6 nonmotor symptoms elicited from an informant. In people with mild cognitive impairment (MCI) or dementia, this scale showed good discriminating abilities when differentiating DLB from Alzheimer disease (AD) and MCI-DLB from MCI-AD. A quality-of-care research program Improving the Diagnosis and Management of Neurodegenerative Dementia of Lewy Body Type (DIAMOND-Lewy) developed an assessment toolkit based on the revised diagnostic criteria to improve diagnostic accuracy. The National Institute on Aging Alzheimers Disease Research Center program added a Lewy body dementia module (LBD-MOD) to the Uniform Data Set to facilitate LBD characterization and diagnosis. The LBD-MOD includes 5 informant-based scales measuring autonomic symptoms, cognitive fluctuations, sleep symptoms and disorders, and neuropsychiatric symptoms, including visual hallucinations.

• #57 Three-Minute Test Detects Common Form of Dementia

  https://www.fau.edu/newsdesk/articles/LewyBody-Test.php

  An FAU neuroscientist has developed a new test that can assess clinical signs and symptoms of Lewy Body dementia, a common form of dementia thats difficult to diagnose, with 96.8 percent accuracy. […] A leading neuroscientist at Florida Atlantic University has developed the Lewy Body Composite Risk Score (LBCRS) to quickly and effectively diagnose LBD and Parkinsons disease dementia (PDD) in about three minutes. […] The LBCRS was able to discriminate between Alzheimers disease and LBD with 96.8 percent accuracy, and provided sensitivity of 90 percent and specificity of 87 percent. […] Most patients never receive an evaluation by a neurologist skilled in the diagnosis of Lewy body dementia, and significant delays and misdiagnoses occur in most patients with this disease, said James E. Galvin, M.D., M.P.H., one of the most prominent neuroscientists in the country who developed the LBCRS.

• #58 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/articles/2024-may-june/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies

  Knowledge of the latest research findings will equip neurologists with the clinical insight necessary to navigate the complexities of dementia with Lewy bodies, enhancing patient care and outcomes. Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia, affecting about 1.5 million people in the United States, but it is underrecognized and often mismanaged in clinical practice. A delayed or nonspecific diagnosis adds to the burden that individuals with DLB and their caregivers experience, and increases the risk of lack of treatment or inappropriate medication use. This review aims to provide practicing neurologists with a comprehensive overview of DLB, encompassing its clinical presentation, diagnostic criteria, and management strategies. […] Diagnostic criteria for a clinical diagnosis of DLB were revised by the DLB Consortium and published in their fourth consensus report in 2017. These criteria have high specificity, but until recently there was no consensus on standard methods to assess signs and symptoms to improve the sensitivity of a DLB diagnosis. However, there are now several tools or sets of instruments that can be used to assess DLB signs and symptoms in a standardized fashion. One of the first was the Lewy Body Composite Score, which includes 5 motor signs of parkinsonism determined by an experienced provider and 6 nonmotor symptoms elicited from an informant. In people with mild cognitive impairment (MCI) or dementia, this scale showed good discriminating abilities when differentiating DLB from Alzheimer disease (AD) and MCI-DLB from MCI-AD. A quality-of-care research program Improving the Diagnosis and Management of Neurodegenerative Dementia of Lewy Body Type (DIAMOND-Lewy) developed an assessment toolkit based on the revised diagnostic criteria to improve diagnostic accuracy. The National Institute on Aging Alzheimers Disease Research Center program added a Lewy body dementia module (LBD-MOD) to the Uniform Data Set to facilitate LBD characterization and diagnosis. The LBD-MOD includes 5 informant-based scales measuring autonomic symptoms, cognitive fluctuations, sleep symptoms and disorders, and neuropsychiatric symptoms, including visual hallucinations.

• #59 Providing the Right Diagnosis for Lewy Body Dementia Patients – InventUMPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–button

  https://news.med.miami.edu/providing-the-right-diagnosis-for-lewy-body-dementia-patients/

  Providing the Right Diagnosis for Lewy Body Dementia Patients […] Lewy body dementia (LBD) may seem obscure, but there are 1.4 million Americans suffering from this disease, making it the second most common form of dementia. To complicate matters, LBD can share symptoms with Alzheimer’s, Parkinson’s, schizophrenia, and other psychiatric conditions, making it challenging to diagnose. […] To remedy this, the Alzheimer’s Disease Research Center program at the National Institute on Aging created an LBD diagnostic module, which more precisely delineates the symptoms associated with it and will give clinicians and researchers better tools to identify the disease. […] The results from this study show the new module is a robust tool and should be a tremendous asset for patients, physicians, and researchers.

• #60 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/articles/2024-may-june/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies

  Knowledge of the latest research findings will equip neurologists with the clinical insight necessary to navigate the complexities of dementia with Lewy bodies, enhancing patient care and outcomes. Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia, affecting about 1.5 million people in the United States, but it is underrecognized and often mismanaged in clinical practice. A delayed or nonspecific diagnosis adds to the burden that individuals with DLB and their caregivers experience, and increases the risk of lack of treatment or inappropriate medication use. This review aims to provide practicing neurologists with a comprehensive overview of DLB, encompassing its clinical presentation, diagnostic criteria, and management strategies. […] Diagnostic criteria for a clinical diagnosis of DLB were revised by the DLB Consortium and published in their fourth consensus report in 2017. These criteria have high specificity, but until recently there was no consensus on standard methods to assess signs and symptoms to improve the sensitivity of a DLB diagnosis. However, there are now several tools or sets of instruments that can be used to assess DLB signs and symptoms in a standardized fashion. One of the first was the Lewy Body Composite Score, which includes 5 motor signs of parkinsonism determined by an experienced provider and 6 nonmotor symptoms elicited from an informant. In people with mild cognitive impairment (MCI) or dementia, this scale showed good discriminating abilities when differentiating DLB from Alzheimer disease (AD) and MCI-DLB from MCI-AD. A quality-of-care research program Improving the Diagnosis and Management of Neurodegenerative Dementia of Lewy Body Type (DIAMOND-Lewy) developed an assessment toolkit based on the revised diagnostic criteria to improve diagnostic accuracy. The National Institute on Aging Alzheimers Disease Research Center program added a Lewy body dementia module (LBD-MOD) to the Uniform Data Set to facilitate LBD characterization and diagnosis. The LBD-MOD includes 5 informant-based scales measuring autonomic symptoms, cognitive fluctuations, sleep symptoms and disorders, and neuropsychiatric symptoms, including visual hallucinations.

• #61 Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies

  https://practicalneurology.com/articles/2024-may-june/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies

  Knowledge of the latest research findings will equip neurologists with the clinical insight necessary to navigate the complexities of dementia with Lewy bodies, enhancing patient care and outcomes. Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia, affecting about 1.5 million people in the United States, but it is underrecognized and often mismanaged in clinical practice. A delayed or nonspecific diagnosis adds to the burden that individuals with DLB and their caregivers experience, and increases the risk of lack of treatment or inappropriate medication use. This review aims to provide practicing neurologists with a comprehensive overview of DLB, encompassing its clinical presentation, diagnostic criteria, and management strategies. […] Diagnostic criteria for a clinical diagnosis of DLB were revised by the DLB Consortium and published in their fourth consensus report in 2017. These criteria have high specificity, but until recently there was no consensus on standard methods to assess signs and symptoms to improve the sensitivity of a DLB diagnosis. However, there are now several tools or sets of instruments that can be used to assess DLB signs and symptoms in a standardized fashion. One of the first was the Lewy Body Composite Score, which includes 5 motor signs of parkinsonism determined by an experienced provider and 6 nonmotor symptoms elicited from an informant. In people with mild cognitive impairment (MCI) or dementia, this scale showed good discriminating abilities when differentiating DLB from Alzheimer disease (AD) and MCI-DLB from MCI-AD. A quality-of-care research program Improving the Diagnosis and Management of Neurodegenerative Dementia of Lewy Body Type (DIAMOND-Lewy) developed an assessment toolkit based on the revised diagnostic criteria to improve diagnostic accuracy. The National Institute on Aging Alzheimers Disease Research Center program added a Lewy body dementia module (LBD-MOD) to the Uniform Data Set to facilitate LBD characterization and diagnosis. The LBD-MOD includes 5 informant-based scales measuring autonomic symptoms, cognitive fluctuations, sleep symptoms and disorders, and neuropsychiatric symptoms, including visual hallucinations.

• #62 Clinical diagnosis of Lewy body dementia | BJPsych Open | Cambridge Core

  https://www.cambridge.org/core/journals/bjpsych-open/article/clinical-diagnosis-of-lewy-body-dementia/90A3E4D7C82285B6682318A60F926607

  Lewy body dementia, consisting of both dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), is considerably under-recognised clinically compared with its frequency in autopsy series. […] This study investigated the clinical diagnostic pathways of patients with Lewy body dementia to assess if difficulties in diagnosis may be contributing to these differences. […] The cases of individuals with DLB took longer to reach a final diagnosis (1.2 v. 0.6 years, P = 0.017), underwent more scans (1.7 v. 1.2, P = 0.002) and had more alternative prior diagnoses (0.8 v. 0.4, P = 0.002), than the cases of those with non-DLB dementia. […] Our results show the pathway to diagnosis of DLB is longer and more complex than for non-DLB dementia. […] For PDD, a diagnosis of dementia was delayed well beyond symptom onset and even treatment.

• #63 Lewy Body Dementia Diagnosis: Key Differences from Other Dementias – Kensington Park Senior Living | Kensington Park Senior Living

  https://kensingtonparkseniorliving.com/lewy-body-dementia-diagnosis/

  Lewy body dementia (LBD) diagnosis can be confusing, overwhelming, and—oftentimes—misleading. […] LBD is one of the most misdiagnosed forms of dementia, often mistaken for Alzheimer’s, Parkinson’s, or even psychiatric disorders. […] Diagnosing LBD is tricky because its symptoms overlap with Alzheimer’s and Parkinson’s, leading to misdiagnosis in nearly 50% of cases. […] There is no single test to confirm LBD, which is why getting evaluated by a specialist familiar with the disease is critical. […] Since LBD symptoms come and go, it can appear like multiple conditions at once, leading to years of incorrect treatment. […] This is why getting a proper diagnosis from a specialist early on can make a world of difference in getting the right care. […] At Kensington Park Senior Living, we know that navigating a Lewy body dementia diagnosis can be overwhelming. […] Contact Kensington Park today to learn how we can support you and your loved one on the journey of a Lewy body dementia diagnosis.

• #64 Differential diagnosis and treatment – a whistle… | Neurology Academy

  https://neurologyacademy.org/articles/differential-diagnosis-and-treatment-a-whistle-stop-tour-of-dementia-with-lewy-bodies

  Lewy body dementia (LBD) and Parkinsons disease dementia (PDD) together account for up to 15% of all dementias. […] Recognition and management of these dementias, though, is often suboptimal, and people living with them can fall through the gaps in care. […] Tim began the session by noting that dementia with Lewy bodies comes with complex motor and cognitive impact and that it is both over and under diagnosed. […] He cited McKeith (1996)’s guidelines for LBD diagnosis and outlined hallucinations as being characteristic when they are (usually) involving people who are still and silent, and not usually frightening. […] Other key observations to help diagnose LBD; those living with LBD: will typically experience massive fluctuations in ability from day to day […] may have mild Parkinsonism but it will usually be upper limb rather than lower limb (which is more common in vascular dementia), and it might look like bradykinesia but it will have a decrement to it.

• #65 Clinical diagnosis of Lewy body dementia | BJPsych Open | Cambridge Core

  https://www.cambridge.org/core/journals/bjpsych-open/article/clinical-diagnosis-of-lewy-body-dementia/90A3E4D7C82285B6682318A60F926607

  The pathway to diagnosis is hence longer and more challenging for patients with DLB. […] The timely diagnosis of DLB is therefore important for providing the necessary clinical care as well as support to the patient and their caregiver. […] We found regional variations in the UK in how DLB was diagnosed, in particular the thresholds clinicians required for a DLB diagnosis and also in their use of FP-CIT scans. […] Such differences in the diagnostic approach of clinicians highlights the need for a more standardised approach. […] Together, the delays in achieving the correct diagnosis and the variations in clinical thresholds set by clinicians for the diagnosis of DLB could be contributing to the differences in the prevalence of DLB reported in clinical and pathological studies. […] This study also shows that a diagnosis of dementia is often delayed in patients with Parkinson’s disease. […] A delay in the diagnosis of dementia has important implications for patients and their caregivers.

• #66 The Difficulty With Diagnosing Lewy Body Dementia in Patients – Altoida

  https://altoida.com/blog/difficulty-with-diagnosing-lewy-body-dementia/

  Accurately diagnosing Lewy body dementia early is essential for patients to receive the right medical care and avoid receiving incorrect and/or potentially harmful treatment. Early detection also allows patients to take the time to plan their medical care, participate in clinical trials, build a support system, and arrange legal and financial affairs. […] Even with earlier, more frequent neurocognitive testing, there are still significant barriers to obtaining an accurate diagnosis. Currently, healthcare providers rely on outdated pencil and paper cognitive tests. These assessments only test a small subset of neurocognitive domains and often produce noisy, highly variable data that lacks the specificity and granularity needed to paint a true, detailed picture of neurocognitive function and, consequently, make a diagnosis without the use of expensive and/or invasive diagnostic tools.

• #67 Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions

  https://www.e-jmd.org/journal/view.php?number=267

  The aim of this article is to describe the 2017 revised consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) with future directions for the diagnostic criteria. […] The 2017 revised criteria clearly distinguish between clinical features and diagnostic biomarkers. […] Future directions include the development of the criteria for early diagnosis (prodromal DLB) and the establishment of new biomarkers that directly indicate Lewy-related pathology, including -synuclein imaging, biopsies of peripheral tissues (skin, etc.) for the demonstration of -synuclein deposition, and biochemical markers (cerebrospinal fluid/blood), as well as the pathological evaluation of the sensitivity and specificity of the 2017 revised diagnostic criteria. […] The 2017 criteria distinguish clearly between clinical features and diagnostic biomarkers, and significant new information about previously reported aspects of DLB has been incorporated into the 2017 revised criteria, with increased diagnostic weighting given to RBD and MIBG.

• #68 The Difficulty With Diagnosing Lewy Body Dementia in Patients – Altoida

  https://altoida.com/blog/difficulty-with-diagnosing-lewy-body-dementia/

  Accurately diagnosing Lewy body dementia early is essential for patients to receive the right medical care and avoid receiving incorrect and/or potentially harmful treatment. Early detection also allows patients to take the time to plan their medical care, participate in clinical trials, build a support system, and arrange legal and financial affairs. […] Even with earlier, more frequent neurocognitive testing, there are still significant barriers to obtaining an accurate diagnosis. Currently, healthcare providers rely on outdated pencil and paper cognitive tests. These assessments only test a small subset of neurocognitive domains and often produce noisy, highly variable data that lacks the specificity and granularity needed to paint a true, detailed picture of neurocognitive function and, consequently, make a diagnosis without the use of expensive and/or invasive diagnostic tools.

• #69 Lewy body dementia | MedLink Neurology

  https://www.medlink.com/handouts/lewy-body-dementia

  Lewy body dementia (LBD) is a complex and challenging brain disorder. […] Diagnosing LBD can be challenging for a number of reasons. Early LBD symptoms are often confused with similar symptoms found in other brain diseases like Alzheimer’s. […] It’s important to know which type of LBD a person has, both to tailor treatment to particular symptoms and to understand how the disease will likely progress. […] Dementia with Lewy bodies is often hard to diagnose because its early symptoms may resemble those of Alzheimer’s, Parkinson’s disease, or a psychiatric illness. […] The good news is that doctors are increasingly able to diagnose LBD earlier and more accurately as researchers identify which symptoms help distinguish it from similar disorders. […] Getting an accurate diagnosis of LBD early on is important so that a person:

• #70 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  People who are diagnosed with Lewy body dementia have a gradual decline in the ability to think. They also have at least two of the following: […] Other symptoms support a Lewy body dementia diagnosis. This includes problems with the autonomic nervous system. When this happens, the body isn’t able to regulate blood pressure, heart rate, body temperature and sweating. […] Sensitivity to medicines that treat psychosis also supports a diagnosis. This is particularly true for medicines such as haloperidol (Haldol). Antipsychotic medicines aren’t used for people with Lewy body dementia because they can make symptoms worse. […] No single test can diagnose Lewy body dementia. The diagnosis is based on your symptoms and by ruling out other conditions. […] Your doctor may check for signs of Parkinson’s disease, strokes, tumors or other medical conditions that can affect the brain and physical function.

• #71 Dementia with Lewy Bodies (DLB) – PsychDB

  https://www.psychdb.com/geri/dementia/lewy-body

  Possible DLB can be diagnosed if: a. Only 1 core clinical feature of DLB is present, with no indicative biomarker evidence, or b. 1 or more indicative biomarkers is present but there are no core clinical features. […] The presence REM sleep behaviour disorder is a highly specific predictor of Lewy-related pathology, and is suggestive of a 90% likelihood of a synucleinopathy. […] Cognitive tests like the Mini-Mental Status Exam (MMSE) and Montreal Cognitive Assessment (MoCA) are useful to characterize global impairment. […] Typical and High Potency Antipsychotics are CONTRAINDICATED in Lewy Body Dementia! A severe sensitivity reaction occurs in an estimated 25-50% of Dementia with Lewy Bodies (DLB) patients administered typical antipsychotic drugs (especially haloperidol). […] Acetylcholinesterase inhibitors should be the first medications used to treat hallucinations and agitation in patients with DLB. Both rivastigmine and donepezil are effective in DLB for improving cognition, global function, and activities of living.

• #72 Differential Diagnosis of Lewy Body Dementia (LBD) | alz.org

  https://www.alz.org/professionals/health-systems-medical-professionals/dementia-diagnosis/differential-diagnosis/differential_diagnosis_of_dementia_with_lewy_bodie

  „Lewy body dementia” (LBD) is a term that includes two related diagnoses: Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia. […] A person with DLB will develop dementia and other LBD symptoms, including possible changes in movement like a tremor. […] A person with Parkinson’s disease dementia will first experience changes in movement, then may develop dementia years later. […] The pattern of cognitive decline in Lewy body dementia, including both dementia with Lewy bodies and Parkinson’s disease dementia, can involve memory impairment, poor judgment and confusion. […] About 50% of Lewy body dementia patients experience rapid eye movement (REM) sleep behavior disorder. In this disorder, the normal suppression of voluntary muscle movement during REM sleep fails to occur, leading to vivid and sometimes violent acting out of dreams. REM sleep disorder in a person with dementia may be diagnostic for Lewy body dementia. […] No drugs are currently approved for treatment of dementia with Lewy bodies by the FDA. […] Lewy body dementia may be the most responsive of any dementia to treatment with cholinesterase inhibitors, but they are not approved for this purpose.

• #73 Dementia with Lewy Bodies (DLB) – PsychDB

  https://www.psychdb.com/geri/dementia/lewy-body

  Possible DLB can be diagnosed if: a. Only 1 core clinical feature of DLB is present, with no indicative biomarker evidence, or b. 1 or more indicative biomarkers is present but there are no core clinical features. […] The presence REM sleep behaviour disorder is a highly specific predictor of Lewy-related pathology, and is suggestive of a 90% likelihood of a synucleinopathy. […] Cognitive tests like the Mini-Mental Status Exam (MMSE) and Montreal Cognitive Assessment (MoCA) are useful to characterize global impairment. […] Typical and High Potency Antipsychotics are CONTRAINDICATED in Lewy Body Dementia! A severe sensitivity reaction occurs in an estimated 25-50% of Dementia with Lewy Bodies (DLB) patients administered typical antipsychotic drugs (especially haloperidol). […] Acetylcholinesterase inhibitors should be the first medications used to treat hallucinations and agitation in patients with DLB. Both rivastigmine and donepezil are effective in DLB for improving cognition, global function, and activities of living.

• #74 The Difficulty With Diagnosing Lewy Body Dementia in Patients – Altoida

  https://altoida.com/blog/difficulty-with-diagnosing-lewy-body-dementia/

  Accurately diagnosing Lewy body dementia early is essential for patients to receive the right medical care and avoid receiving incorrect and/or potentially harmful treatment. Early detection also allows patients to take the time to plan their medical care, participate in clinical trials, build a support system, and arrange legal and financial affairs. […] Even with earlier, more frequent neurocognitive testing, there are still significant barriers to obtaining an accurate diagnosis. Currently, healthcare providers rely on outdated pencil and paper cognitive tests. These assessments only test a small subset of neurocognitive domains and often produce noisy, highly variable data that lacks the specificity and granularity needed to paint a true, detailed picture of neurocognitive function and, consequently, make a diagnosis without the use of expensive and/or invasive diagnostic tools.

• #75 Diagnosis and Prognosis – Lewy Body Dementia Association

  https://www.lbda.org/diagnosis-and-prognosis/

  Geriatricians, who specialize in treating older adults, are also usually familiar with the different forms of dementia. […] The prognosis is different for each person and may be affected by their general health or the existence of unrelated illnesses. […] Because LBD progresses at varying rates for each individual, it is not possible to determine how long someone may live with the disease. […] Research suggests most people live five to eight years with LBD.

• #76 Dementia with Lewy Bodies (DLB) – PsychDB

  https://www.psychdb.com/geri/dementia/lewy-body

  Dementia with Lewy Bodies (DLB), is a neurodegenerative disorder associated with abnormal deposits of alpha-synuclein in the brain. DLB is one of the most common causes of dementia. […] Lewy body dementia (LBD) (more correctly, should be referred to as Lewy Body Dementia) is actually an umbrella term that refers either a diagnosis of Dementia with Lewy bodies (DLB) or Parkinson’s disease dementia. […] DLB is estimated to account for around 4.2% of all diagnosed dementias in the community. However, the true prevalence is likely to be much higher because DLB diagnoses are often missed. […] Dementia with Lewy Bodies (DLB) has a very quick progression relative to other dementias such as Alzheimer’s, with an average survival time of 3 to 5 years. […] The presence of REM sleep behaviour disorder is a major risk factor for DLB.

• #77 Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions

  https://www.e-jmd.org/journal/view.php?number=267

  The aim of this article is to describe the 2017 revised consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) with future directions for the diagnostic criteria. […] The 2017 revised criteria clearly distinguish between clinical features and diagnostic biomarkers. […] Future directions include the development of the criteria for early diagnosis (prodromal DLB) and the establishment of new biomarkers that directly indicate Lewy-related pathology, including -synuclein imaging, biopsies of peripheral tissues (skin, etc.) for the demonstration of -synuclein deposition, and biochemical markers (cerebrospinal fluid/blood), as well as the pathological evaluation of the sensitivity and specificity of the 2017 revised diagnostic criteria. […] The 2017 criteria distinguish clearly between clinical features and diagnostic biomarkers, and significant new information about previously reported aspects of DLB has been incorporated into the 2017 revised criteria, with increased diagnostic weighting given to RBD and MIBG.

• #78 Lewy body dementia – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/diagnosis-treatment/drc-20352030

  A short form of this test, which assesses memory and thinking skills, can be done in less than 10 minutes. […] Longer tests that take several hours help identify Lewy body dementia. […] These can rule out physical problems that can affect brain function, such as vitamin B-12 deficiency or an underactive thyroid gland. […] Your doctor might order an MRI or CT scan to identify a stroke or bleeding and to rule out a tumor. […] If the diagnosis is unclear or the symptoms aren’t typical, you may need other imaging tests. […] These imaging tests may support a diagnosis of Lewy body dementia: […] You may need a sleep evaluation called a polysomnogram to check for REM sleep behavior disorder. […] In some countries, health care professionals also might order a heart test called myocardial scintigraphy. […] Research is ongoing into other indicators of Lewy body dementia. These biomarkers might eventually enable early diagnosis of Lewy body dementia before the full disease develops.

• #79 Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions

  https://www.e-jmd.org/journal/view.php?number=267

  For the diagnosis of probable DLB, two or more core clinical features or one core clinical feature, but with one or more indicative biomarkers is required. […] The diagnosis of probable DLB is not allowed on the basis of only biomarkers. […] To further improve the 2017 revised diagnostic criteria for DLB, future directions include the evaluation of the sensitivity and specificity of the 2017 revised criteria by pathologically confirmed cases; the development of the criteria for prodromal DLB, and, further, preclinical DLB to detect early-stage disease; and the establishment of new biomarkers as well as further characterization of clinical features specific to DLB. […] The diagnostic criteria for prodromal DLB are under development. […] The revised consensus criteria for the clinical diagnosis of DLB were published in 2017 with the incorporation of new information about DLB.

• #80 Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions

  https://www.e-jmd.org/journal/view.php?number=267

  The aim of this article is to describe the 2017 revised consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) with future directions for the diagnostic criteria. […] The 2017 revised criteria clearly distinguish between clinical features and diagnostic biomarkers. […] Future directions include the development of the criteria for early diagnosis (prodromal DLB) and the establishment of new biomarkers that directly indicate Lewy-related pathology, including -synuclein imaging, biopsies of peripheral tissues (skin, etc.) for the demonstration of -synuclein deposition, and biochemical markers (cerebrospinal fluid/blood), as well as the pathological evaluation of the sensitivity and specificity of the 2017 revised diagnostic criteria. […] The 2017 criteria distinguish clearly between clinical features and diagnostic biomarkers, and significant new information about previously reported aspects of DLB has been incorporated into the 2017 revised criteria, with increased diagnostic weighting given to RBD and MIBG.

• #81 Diagnosis – Lewy Body Dementia Resource Center

  https://lewybodyresourcecenter.org/what-is-lbd/diagnosis/

  Many doctors and other health care professionals are not familiar with LBD, so people may see several physicians before receiving a correct diagnosis. […] A general practitioner is usually the first professional visited by persons who are encountering changes in thinking, behavior, or movement. But, neurologists more frequently have the knowledge required to diagnose LBD. Geriatric psychiatrists, neuropsychologists, and geriatricians may also be skilled in diagnosing the condition. […] Currently, there are no scans or tests that can absolutely diagnose LBD. The disease can only be diagnosed completely through a brain autopsy after death. […] However, medical professionals may conduct various tests to identify LBD from other diseases. […] The following tests can help support an LBD diagnosis: REM sleep test, DaTscan, PET scan, MRI, Amprion SYNTAP Biomarker Test (spinal fluid test), Skin biopsy that is highly sensitive and specific for LBD and other alpha-synuclein disorders such as Parkinsons.

• #82 Dementia with Lewy Bodies | Baylor Medicine

  https://www.bcm.edu/healthcare/specialties/neurology/parkinsons-disease-and-movement-disorders/dementia-with-lewy-bodies

  DLB is named after deposits (cellular inclusions) called Lewy bodies, which are collections of an abnormal protein called alpha-synuclein. […] While clinical criteria have been published and revised, accurate diagnosis of DLB remains challenging. One study published in 2024 by Coughlin et al. showed that a substantial proportion of clinically diagnosed participants with DLB had negative alpha-Synuclein Seeding Amplification Assay (Syn-SAA) results. The study also found that reduced sense of smell (hyposmia) was the strongest clinical predictor of Syn-SAA positivity. Thus, the researchers concluded that hyposmia and Syn-SAA may have utility in improving the diagnostic assessment of people with potential DLB.

• #83 Patients with dementia with Lewy bodies display a signature alteration of their cognitive connectome | Scientific Reports

  https://www.nature.com/articles/s41598-024-84946-4

  Our results showed alterations in the cognitive connectome of DLB patients driven by global and nodal alterations across features of integration, segregation, and centrality. […] This finding may have clinical implications. […] Advancing our currently limited understanding of the complex associations among cognitive measures and clinical phenotype in DLB may help improve its differential diagnosis with AD and other dementias. […] This study helps advance our current understanding of cognitive impairment and clinical phenotype in DLB, and aids in its clinical discrimination from AD, a diagnostic group that can be confused with DLB clinically.

• #84 Clinical diagnosis of Lewy body dementia | BJPsych Open | Cambridge Core

  https://www.cambridge.org/core/journals/bjpsych-open/article/clinical-diagnosis-of-lewy-body-dementia/90A3E4D7C82285B6682318A60F926607

  The pathway to diagnosis is hence longer and more challenging for patients with DLB. […] The timely diagnosis of DLB is therefore important for providing the necessary clinical care as well as support to the patient and their caregiver. […] We found regional variations in the UK in how DLB was diagnosed, in particular the thresholds clinicians required for a DLB diagnosis and also in their use of FP-CIT scans. […] Such differences in the diagnostic approach of clinicians highlights the need for a more standardised approach. […] Together, the delays in achieving the correct diagnosis and the variations in clinical thresholds set by clinicians for the diagnosis of DLB could be contributing to the differences in the prevalence of DLB reported in clinical and pathological studies. […] This study also shows that a diagnosis of dementia is often delayed in patients with Parkinson’s disease. […] A delay in the diagnosis of dementia has important implications for patients and their caregivers.

• #85 Diagnosis and management of dementia with Lewy bodies

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5496518/

  The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade. […] The revised DLB consensus criteria now distinguish clearly between clinical features and diagnostic biomarkers, and give guidance about optimal methods to establish and interpret these. […] Substantial new information has been incorporated about previously reported aspects of DLB, with increased diagnostic weighting given to REM sleep behavior disorder and 123iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy. […] The diagnostic role of other neuroimaging, electrophysiologic, and laboratory investigations is also described. […] Minor modifications to pathologic methods and criteria are recommended to take account of Alzheimer disease neuropathologic change, to add previously omitted Lewy-related pathology categories, and to include assessments for substantia nigra neuronal loss.

• #86 Providing the Right Diagnosis for Lewy Body Dementia Patients – InventUMPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–buttonPage 1arrow–button

  https://news.med.miami.edu/providing-the-right-diagnosis-for-lewy-body-dementia-patients/

  “This module taps into all of the main features of Lewy body dementia,” said Miller School neurologist and professor of neurology James Galvin, M.D., M.P.H., who led the work group that developed the module and is senior author on the paper. “The tool discriminated LBD from Alzheimer’s disease and healthy controls, as well as between mild cognitive impairment due to Alzheimer’s disease and mild cognitive impairment due to LBD. Most importantly, the diagnostic instruments selected for the module discriminated in a powerful fashion.” […] The study showed the new module had the diagnostic firepower to effectively delineate patients in each of these groups, giving it great potential to reduce misdiagnoses. […] These findings are important because misdiagnosis is a common problem that can have tragic consequences. In addition to not receiving the best treatments, misdiagnosed LBD patients can have severe reactions to incorrect medications, including death.

• #87 Diagnosis and management of dementia with Lewy bodies

  https://pmc.ncbi.nlm.nih.gov/articles/PMC5496518/

  Recommendations about clinical management are largely based upon expert opinion since randomized controlled trials in DLB are few. […] There remains a pressing need to understand the underlying neurobiology and pathophysiology of DLB, to develop and deliver clinical trials with both symptomatic and disease-modifying agents, and to help patients and carers worldwide to inform themselves about the disease, its prognosis, best available treatments, ongoing research, and how to get adequate support.

Zobacz więcej